← Karyopharm Therapeutics (KPTI)
Karyopharm Therapeutics SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedKaryopharm Therapeutics Files Chapter 11 and Signs Restructuring Support Agreement for Merger with Ayrmid; Common Stock Expected to Have No Value
Other events
AI summary, unreviewedKaryopharm Therapeutics extends forbearance period on indentures to November 1, 2026
Other events
AI summary, unreviewedKaryopharm Therapeutics extends forbearance period on indentures to October 22, 2026
Material modification of security holders' rights · Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits
Entry into a material definitive agreement · Triggering events accelerating an obligation · Unregistered sales of equity securities · Other events · Financial statements and exhibits
Other events
Results of operations and financial condition · Financial statements and exhibits
Other events